Archives

Usha Menon, MD, is Professor of Gynecological Oncology and Lead, Training and Capacity Strengthening at the Medical Research Council Clinical Trials Unit at UCL (University College London) and honorary Consultant Gynecologist at UCLH NHS Foundation Trust in London. She is a Fellow of the Royal College of Obstetrics and Gynecology, UK.

Dr. Menon’s research focuses on the early detection and prevention of gynecologic malignancies, in particular ovarian cancer.

She was one of the principal investigators on the UK ovarian cancer screening trials and studies exploring symptoms of ovarian cancer. The latter includes the UK Collaborative Trial of Ovarian Cancer Screening – a randomized control trial of over 202,000 women.

Additional research interests include genetic and environmental risk factors and novel biomarkers for ovarian cancers and early detection of other cancers.

Dr. Menon began her training at Christian Medical College, Vellore, India and received her MBBS and MD in Obstetrics and Gynecology from the University of Madras, India. She continued her specialist training in UK and received her Certificate for Completion of Training (CCT) in Obstetrics and Gynecology from the Royal College of Obstetrics and Gynecology, UK and her research degree – MD(Res) – from UCL.

Dr. Karen Lu is the executive vice president and physician in chief at Moffitt Cancer Center. She is responsible for overseeing the Moffitt Medical Group, Florida’s largest multidisciplinary medical group practice made up of over 600 faculty members and advanced practice providers.

As a nationally recognized-physician scientist, Lu focuses her clinical and research interests on the surgical and medical treatment of women with ovarian and endometrial cancers, as well as the management of women at genetically high risk for these cancers. She is a national leader in the cancer genetics field, publishing seminal articles on heredity gynecological cancers.

Lu has more than 15 years of health care leadership experience. Prior to joining Moffitt, she most recently served as the chair of the Department of Gynecologic Oncology and Reproductive Medicine and co-director of the Clinical Cancer Genetics program at MD Anderson Cancer Center. She previously served as the ad interim chief clinical officer at MD Anderson.

Lu earned her bachelor’s degree in biochemical sciences from Harvard University and completed her medical studies at Yale University School of Medicine. She subsequently obtained her master’s in health care management from the Harvard T.H. Chan School of Public Health. She serves on the American Society of Clinical Oncology (ASCO) Research Committee and is the incoming president-elect of the Society of Gynecologic Oncology (SGO). She is an elected member of the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP).